13,332 Shares in Stryker Corporation $SYK Acquired by Field & Main Bank

Posted by Geri Gentry on Aug 29th, 2026

Field & Main Bank bought a new stake in shares of Stryker Corporation (NYSE:SYK – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor bought 13,332 shares of the medical technology company’s stock, valued at approximately $4,197,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank acquired a new position in shares of Stryker during the fourth quarter worth $1,822,272,000. Bank of America Corp DE acquired a new stake in shares of Stryker in the 2nd quarter worth $1,404,284,000. Auto Owners Insurance Co grew its stake in Stryker by 35,047.0% during the 4th quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after buying an additional 2,906,448 shares during the last quarter. Legal & General Group Plc purchased a new position in Stryker during the 2nd quarter worth $707,212,000. Finally, Jupiter Topco LLC acquired a new position in Stryker during the 2nd quarter valued at about $681,581,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 300,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dylan Bram Crotty sold 441 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 351,267 shares of company stock valued at $118,197,701 over the last quarter. 4.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on SYK. Wells Fargo & Company lowered their price target on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Sanford C. Bernstein set a $410.00 price objective on Stryker in a research note on Friday, May 1st. Leerink Partners decreased their price objective on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. BTIG Research dropped their target price on Stryker from $371.00 to $358.00 and set a “buy” rating on the stock in a research report on Friday, July 31st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $386.28.

Check Out Our Latest Research Report on Stryker

Stryker Stock Performance

SYK opened at $331.32 on Friday. The firm’s fifty day simple moving average is $329.10 and its two-hundred day simple moving average is $331.47. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86. The company has a market cap of $127.08 billion, a price-to-earnings ratio of 34.33, a PEG ratio of 2.05 and a beta of 0.76. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK – Get Free Report) last released its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the company earned $3.13 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s payout ratio is 36.48%.

Stryker Company Profile

(Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.